Gossamer Bio Inc. announced the closing of a $230 million Series B preferred stock financing led by Hillhouse Capital. In connection with the financing, Gossamer Bio further announced that Sheila Gujrathi, M.D., Co-Founder and current President & Chief Operating Officer, has become the Chief Executive Officer, and Co-Founder Faheem Hasnain becomes full time Executive Chairman.